BIOLASE Granted Regulatory Approval to Sell Waterlase iPlus All-Tissue Dental Laser Systems in South Korea

Loading...
Loading...
BIOLASE Technology, Inc.
BLTI
, announced today that it has received approval from the Korean Food and Drug Administration to sell its Waterlase iPlus all-tissue dental laser systems throughout South Korea. South Korea has an estimated 25,000 dentists and 16,000 dental clinics, and their progressive dental practitioners have been particularly prone to adopting high-tech dental equipment, including more than 1,000 practices that currently use one or more BIOLASE dental lasers.
Market News and Data brought to you by Benzinga APIs
Posted In: NewsFDA
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...